| 1.01 -0.19 (-15.83%) | 03-19 15:43 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.85 | 1-year : | 2.81 |
| Resists | First : | 1.59 | Second : | 2.4 |
| Pivot price | 0.96  |
|||
| Supports | First : | 0.27 | Second : | 0.22 |
| MAs | MA(5) : | 0.91 |
MA(20) : | 1.24 |
| MA(100) : | 2.55 |
MA(250) : | 5.39 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 40.9 |
D(3) : | 34.8 |
| RSI | RSI(14): 43.3 |
|||
| 52-week | High : | 13.74 | Low : | 0.27 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RBOT ] has closed below upper band by 47.8%. Bollinger Bands are 45.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.2 - 1.21 | 1.21 - 1.21 |
| Low: | 0.89 - 0.89 | 0.89 - 0.9 |
| Close: | 1 - 1.01 | 1.01 - 1.02 |
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Wed, 18 Mar 2026
Vicarious Surgical sees FY2026 cash burn of $35 million - MSN
Tue, 17 Mar 2026
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing - Orthopedics This Week
Fri, 13 Mar 2026
Reverse split proposal aims to relist Class A shares (RBOT) on Nasdaq - Stock Titan
Fri, 13 Mar 2026
ETFs Investing in Vicarious Surgical, Inc. Class A Stocks - TradingView
Thu, 12 Mar 2026
Preferred dividends of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Mon, 09 Mar 2026
Vicarious Surgical projects cash burn drop from $45.1M to $19M - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 6 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 18.3 (%) |
| Held by Institutions | 33.2 (%) |
| Shares Short | 384 (K) |
| Shares Short P.Month | 309 (K) |
| EPS | -9.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.35 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -63.4 % |
| Return on Equity (ttm) | -149 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -8.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -48 (M) |
| Levered Free Cash Flow | -28 (M) |
| PE Ratio | -0.12 |
| PEG Ratio | 0 |
| Price to Book value | 0.42 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|